CCZ bromelain fraction (Incitive)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCCZ bromelain fraction (Incitive)
Drug Alias NameICV-0026
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCathepsin B modulators
TargetsCathepsin B
Therapy Area/IndicationsImmunologic Deficiency SyndromesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSarantis Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSarantis Pty Ltd
Active IndicationsN/A
Inactive IndicationsImmunologic Deficiency SyndromesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A